Pharmaceutical Microbiology 20th January to 21st January 2015, London, United Kingdom

Pharmaceutical microbiology is of crucial importance to the development and manufacture of pharmaceutical drugs, biologics and devices. Set to take place on the 21st and 22nd January 2015, the event will provide essential insights in to the latest advancements in practice and technology, developments in regulation and harmonisation of international practice and evolving methods and the latest technology

Join us as we explore key issues in data review and analysis, contamination control strategies, strategies for low endotoxin recovery and best practice in sterile and non-sterile manufacture. Hear presentations from the heart of industry, addressing real world case studies on the benefits and challenges of rapid methods, risk assessments and objectionable organisms. Share the wisdom of respected consultants and get the regulators perspective on recent changes and issues under review.

Pharmaceutical Microbiology 20th January to 21st January 2015, London, United Kingdom

Pharmaceutical microbiology is of crucial importance to the development and manufacture of pharmaceutical drugs, biologics and devices. Set to take place on the 21st and 22nd January 2015, the event will provide essential insights in to the latest advancements in practice and technology, developments in regulation and harmonisation of international practice and evolving methods and the latest technology

Join us as we explore key issues in data review and analysis, contamination control strategies, strategies for low endotoxin recovery and best practice in sterile and non-sterile manufacture. Hear presentations from the heart of industry, addressing real world case studies on the benefits and challenges of rapid methods, risk assessments and objectionable organisms. Share the wisdom of respected consultants and get the regulators perspective on recent changes and issues under review.

Social Media in the Pharmaceutical Industry 21st January to 22nd January 2015, London, UK

SMi present their 7th Annual Social Media in the Pharmaceutical Industry conference.  Markets have become conversations. Social media is the online platform and location that provides a way for people to participate in these conversations. It’s a way to tap into what people are saying about a brand, a product or a service: participate in these conversations, be open to new ideas and then use these insights to make better business decisions. Lately, Social Media has also played an important role in disseminating information to the consumers.

As the pharmaceutical industry is advancing, more and more companies are now taking to various mediums like mobile applications, internet and blogs to be socially visible. These channels help them to reach a wider mass and thereby interact not only with like-minded people, but also consumers.

This year's Conference will deliberate on topics such as regulatory insights, consumer focused approach, mobile & website advances, vision for 2015 to name but a few.

You simply cannot afford to miss out.

Social Media in the Pharmaceutical Industry 21st January to 22nd January 2015, London, UK

SMi present their 7th Annual Social Media in the Pharmaceutical Industry conference.  Markets have become conversations. Social media is the online platform and location that provides a way for people to participate in these conversations. It’s a way to tap into what people are saying about a brand, a product or a service: participate in these conversations, be open to new ideas and then use these insights to make better business decisions. Lately, Social Media has also played an important role in disseminating information to the consumers.

As the pharmaceutical industry is advancing, more and more companies are now taking to various mediums like mobile applications, internet and blogs to be socially visible. These channels help them to reach a wider mass and thereby interact not only with like-minded people, but also consumers.

This year's Conference will deliberate on topics such as regulatory insights, consumer focused approach, mobile & website advances, vision for 2015 to name but a few.

You simply cannot afford to miss out.

Pre-Filled Syringes 28th January to 29th January 2015, London, United Kingdom

SMi are pleased to present Europe’s leading Pre-Filled Syringes Conference with 7 years of excellence at this well-established two day conference taking place on 28th- 29th January 2015.

The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. This field is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. With the pharmaceutical industry expected to invest $10 billion of growth by 2018, the consensus is that sterile injectables remain an attractive prospect with room for significant growth to improve the quality of patients’ lives.

Pre-Filled Syringes are a fast and effective way to administer drugs and, as many pharmaceutical companies invest, the challenges faced for improvements still stand and must be addressed.

Pre-Filled Syringes 28th January to 29th January 2015, London, United Kingdom

SMi are pleased to present Europe’s leading Pre-Filled Syringes Conference with 7 years of excellence at this well-established two day conference taking place on 28th- 29th January 2015.

The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. This field is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. With the pharmaceutical industry expected to invest $10 billion of growth by 2018, the consensus is that sterile injectables remain an attractive prospect with room for significant growth to improve the quality of patients’ lives.

Pre-Filled Syringes are a fast and effective way to administer drugs and, as many pharmaceutical companies invest, the challenges faced for improvements still stand and must be addressed.

3rd Immunogenicity and Immunotoxicity Conference on January 29-30, 2015 in San Diego, CA

The conference will cover important progress made in the areas of therapeutic protein immunogenicity and immunotoxicity evaluation such as protein aggregation, clinical relevance and assessment of immunogenicity, mitigation of immunogenicity-related risks, biosimilar development, and immunotoxicity evaluation strategies.

Guests will get an up-to-date understanding of the mechanisms and consequences of protein aggregation and insights on how to prosecute state-of-the-art assessment of the clinical immunogenicity of therapeutic proteins.

Sessions for the 2015 program:

I. Immunotoxicity Evaluation of Novel Drug Candidates
II. Immunotoxicity and Drug Hypersensitivity
III. Immunogenicity Assessment for Biosimilars
IV. Immunogenicity Assessment for Peptide Therapeutics
V. Protein Aggregation, Biological Activity and Immunogenicity
VI. Computational Methods for Immunogenicity Evaluation

https://www.gtcbio.com/conferences/immunogenicity-immunotoxicity-overview

Cytokines & Inflammation Conference on January 29-30, 2015 in San Diego, CA

GTCbio invites you to the 13th Annual Cytokines & Inflammation Conference, held on January 29-30, 2015 in San Diego, CA.

Some topics that will be discussed include developments in the therapeutic application of cytokines and proposal of new targets, the complex relationship between the immune system and microbes in the homeostasis of mucosal tissues, new findings in the biology and regulation of IL-23 and IL-17, novel means to modulate immune pathways to promote anti-tumor activity, and many more.

Session topics include:

I. Metabolism, Cytokines and Immunity
II. Cytokines and the Impact of the Microbiome
III. Advances in Innate and Adaptive Immunity
IV. Cytokines and Cancer Immunotherapy
V. Targeting Cytokines & Chemokines for Therapeutic Interventions

Join us for not only presentations on the latest research, but networking sessions where you will meet and collaborate with fellow researchers on the future of cytokines research!

https://www.gtcbio.com/conferences/cytokines-inflammation-overview

Immunotherapeutics & Immunomonitoring Conference on January 29-30, 2015 in San Diego, CA

GTC is proud to present the 7th Immunotherapeutics & Immunomonitoring Conference held on January 29-30, 2015 in San Diego, CA.

Leading experts will present about novel findings and developments in the constantly changing area of immunological assays and procedures. They will also discuss recent advances in immunotherapy, as they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment. Potential clinical feasibility and commercial potential of the newest data obtained from leading biomedical research laboratories will also be discussed.

Network with colleagues to discuss an update on state-of-the-art immunomonitoring, novel strategies to identify and validate biomarkers predictive for clinical efficacy, novel strategies to identify and clinically develop synergistic combination therapies, and outlook on novel druggable targets for immunotherapy.

Session Topics:

I. Disease & Tumor Microenvironment
II. Novel Targets in Immune Therapeutics
III. Novel Therapeutic Approaches
IV. Combinatorial Immunotherapies
V. Immunomonitoring

https://www.gtcbio.com/conferences/immunotherapeutics-immunomonitoring-overview

Novel Immunotherapeutics Summit on Jan 29-30,2015 San Diego, CA

GTCbio invites you to the Novel Immunotherapeutics Summit, which takes place January 29-30, 2015 in San Diego, CA. The summit will have a balance of industry and academia, so delegates have the opportunity to network with colleagues from different sectors and gain fresh perspective on the various research happening.

The summit has three concurrent conferences:

13th Cytokines & Inflammation
This meeting provides a forum for researchers to discuss the latest advances in targeting cytokines and chemokines for therapeutic interventions, cytokines and metabolism, cytokines signaling pathways, and much more.

7th Immunotherapeutics & Immunomonitoring
Leading experts will cover recent advances in immunotherapy and how they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment.

3rd Immunogenicity and Immunotoxicity
Delegates will learn about ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins. Also get an up-to-date understanding of protein aggregation and therapeutic proteins.

https://www.gtcbio.com/conferences/immunotherapeutics-summit-overview

3rd Immunogenicity and Immunotoxicity Conference on January 29-30, 2015 in San Diego, CA

The conference will cover important progress made in the areas of therapeutic protein immunogenicity and immunotoxicity evaluation such as protein aggregation, clinical relevance and assessment of immunogenicity, mitigation of immunogenicity-related risks, biosimilar development, and immunotoxicity evaluation strategies.

Guests will get an up-to-date understanding of the mechanisms and consequences of protein aggregation and insights on how to prosecute state-of-the-art assessment of the clinical immunogenicity of therapeutic proteins.

Sessions for the 2015 program:

I. Immunotoxicity Evaluation of Novel Drug Candidates
II. Immunotoxicity and Drug Hypersensitivity
III. Immunogenicity Assessment for Biosimilars
IV. Immunogenicity Assessment for Peptide Therapeutics
V. Protein Aggregation, Biological Activity and Immunogenicity
VI. Computational Methods for Immunogenicity Evaluation

https://www.gtcbio.com/conferences/immunogenicity-immunotoxicity-overview

Cytokines & Inflammation Conference on January 29-30, 2015 in San Diego, CA

GTCbio invites you to the 13th Annual Cytokines & Inflammation Conference, held on January 29-30, 2015 in San Diego, CA.

Some topics that will be discussed include developments in the therapeutic application of cytokines and proposal of new targets, the complex relationship between the immune system and microbes in the homeostasis of mucosal tissues, new findings in the biology and regulation of IL-23 and IL-17, novel means to modulate immune pathways to promote anti-tumor activity, and many more.

Session topics include:

I. Metabolism, Cytokines and Immunity
II. Cytokines and the Impact of the Microbiome
III. Advances in Innate and Adaptive Immunity
IV. Cytokines and Cancer Immunotherapy
V. Targeting Cytokines & Chemokines for Therapeutic Interventions

Join us for not only presentations on the latest research, but networking sessions where you will meet and collaborate with fellow researchers on the future of cytokines research!

https://www.gtcbio.com/conferences/cytokines-inflammation-overview

Immunotherapeutics & Immunomonitoring Conference on January 29-30, 2015 in San Diego, CA

GTC is proud to present the 7th Immunotherapeutics & Immunomonitoring Conference held on January 29-30, 2015 in San Diego, CA.

Leading experts will present about novel findings and developments in the constantly changing area of immunological assays and procedures. They will also discuss recent advances in immunotherapy, as they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment. Potential clinical feasibility and commercial potential of the newest data obtained from leading biomedical research laboratories will also be discussed.

Network with colleagues to discuss an update on state-of-the-art immunomonitoring, novel strategies to identify and validate biomarkers predictive for clinical efficacy, novel strategies to identify and clinically develop synergistic combination therapies, and outlook on novel druggable targets for immunotherapy.

Session Topics:

I. Disease & Tumor Microenvironment
II. Novel Targets in Immune Therapeutics
III. Novel Therapeutic Approaches
IV. Combinatorial Immunotherapies
V. Immunomonitoring

https://www.gtcbio.com/conferences/immunotherapeutics-immunomonitoring-overview

Novel Immunotherapeutics Summit on Jan 29-30,2015 San Diego, CA

GTCbio invites you to the Novel Immunotherapeutics Summit, which takes place January 29-30, 2015 in San Diego, CA. The summit will have a balance of industry and academia, so delegates have the opportunity to network with colleagues from different sectors and gain fresh perspective on the various research happening.

The summit has three concurrent conferences:

13th Cytokines & Inflammation
This meeting provides a forum for researchers to discuss the latest advances in targeting cytokines and chemokines for therapeutic interventions, cytokines and metabolism, cytokines signaling pathways, and much more.

7th Immunotherapeutics & Immunomonitoring
Leading experts will cover recent advances in immunotherapy and how they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment.

3rd Immunogenicity and Immunotoxicity
Delegates will learn about ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins. Also get an up-to-date understanding of protein aggregation and therapeutic proteins.

https://www.gtcbio.com/conferences/immunotherapeutics-summit-overview